News & Events

News & Events

PranaX: Diamond Sponsor at the 2023 AAEV Conference Boston

May 19, 2024

(HOUSTON) – We are proud to reflect on our role as a Diamond Sponsor for the American Association of Extracellular Vesicles (AAEV) conference, which took place in Boston, Massachusetts from October 27-29, 2023. This prestigious event was dedicated to the advancement of knowledge in the field of extracellular vesicles, promoting their development, dissemination, integration, and utilization across various scientific and medical disciplines.

Extracellular vesicles are small particles released by cells that play crucial roles in intercellular communication, disease mechanisms, and potential therapeutic applications. The AAEV is at the forefront of fostering research and innovation in this rapidly evolving field, bringing together experts and enthusiasts to share groundbreaking findings and collaborate on future initiatives.

The 2023 AAEV Annual Meeting was a remarkable gathering of esteemed professionals from around the world. Attendees engaged in in-depth discussions and presentations on the latest discoveries and technological advancements related to extracellular vesicles. The conference provided a platform for networking, collaboration, and the exchange of ideas.

We were honored that PranaX scientific co-founders, Dr. Raghu Kalluri, MD/PhD and Dr. Valerie LeBleu, MD/PhD, MBA, actively participated in the conference. Dr. Kalluri, who served on the organizing committee and is the current president of the AAEV, brought a wealth of knowledge and leadership to the event. Alongside him, Dr. LeBleu, a distinguished scientist in the field, shared her
insights and research findings with attendees. As a leader in the biotech industry, PranaX is committed to pioneering advancements in EV research and technology. Our sponsorship of the AAEV conference underscored our dedication to supporting the
scientific community and contributing to the collective understanding of extracellular vesicles.

Reflecting on our participation in the 2023 AAEV conference, we are more motivated than ever to continue our work in the field of extracellular vesicles. This event was an invaluable opportunity for learning, networking, and advancing the science of extracellular vesicles. We look forward to supporting and participating in the next AAEV conference this November 2024 in Houston, Texas, where PranaX’s own Dr. Valerie LeBleu, MD/PhD, MBA, will serve as a co-chair. We’re excited to continue contributing to the remarkable work being done in this field.

Together, let’s push the boundaries of science and unlock the full potential of extracellular vesicles.

American Association of Extracellular Vesicles – Houston, TX | November 10-13

Save the Date: November 10-13, 2024

Register Here

The 2nd AAEV meeting invites scientists from academia and industry! AAEV promotes the development, dissemination, integration, and utilization of knowledge in the field of extracellular vesicles (EV). The Association provides a platform for researchers to learn, disseminate, and network with EV researchers worldwide through Annual Conferences, peer-reviewed journal, initiatives, and industry partnerships.

PranaX: Revolutionizing Biotechnology at Levit Green

April 30, 2024

(HOUSTON) – PranaX stands at the forefront of biotechnology, dedicated to harnessing the potential of exosomes to rejuvenate aging, inflamed, and damaged tissues and organs. The company aims to commercialize exosomes as therapeutics, natural supplements, and wellness products, paving the way for healthier, more fulfilling lives.

Hines, in collaboration with 2ML Real Estate Interests and Harrison Street, proudly unveils the latest addition to Levit Green, Houston’s premier life sciences campus. PranaX, a trailblazing biotech firm specializing in regenerative science, has secured a cutting-edge laboratory space spanning 7,400 square feet on the second floor of Levit Green’s Phase I building. This move signifies PranaX’s commitment to advancing scientific innovation within Houston.

Levit Green, completed in 2023, represents a pinnacle of modern laboratory and biomanufacturing facilities designed to accommodate the evolving needs of the life sciences industry. The Phase I building, spanning 290,000 square feet across five stories, offers turnkey laboratory suites equipped with state-of-the-art amenities. Moreover, the building features 25,000 square feet of dedicated lab incubator space, fostering collaboration and networking opportunities for emerging businesses in the life sciences sector.

Steven J. Greco, PhD, Founder and Chief Operating Officer of PranaX, expresses his enthusiasm for the company’s new home within the state-of-the-art facilities of Levit Green. “This is an amazing opportunity to retain technology developed locally and expand upon it within the Houston biotech ecosystem,” says Dr. Greco, highlighting the synergies between PranaX’s vision and the vibrant scientific community of Houston.

In collaboration with Hines, PranaX is poised to establish an ISO-7 clean room meeting FDA standards within Levit Green. This clean room will play a pivotal role in manufacturing approved therapies for patients at PranaX’s offsite clinic, further augmenting the suite’s capabilities for cutting-edge research and development. Additionally, PranaX plans to leverage this space to offer innovative exosome banking services, catering to the growing demand for personalized medicine and breakthrough treatments.

PranaX’s relocation to Levit Green marks a significant milestone in Houston’s biotech landscape, underscoring the city’s role as a hub for scientific innovation and technological advancement. As PranaX embarks on its journey within Levit Green’s dynamic ecosystem, the stage is set for groundbreaking discoveries and transformative advancements in regenerative medicine.